BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23378343)

  • 1. MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients.
    Pu X; Roth JA; Hildebrandt MA; Ye Y; Wei H; Minna JD; Lippman SM; Wu X
    Cancer Res; 2013 Mar; 73(6):1867-75. PubMed ID: 23378343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer.
    Lee SY; Choi JE; Jeon HS; Hong MJ; Choi YY; Kang HG; Yoo SS; Lee EB; Jeong JY; Lee WK; Lee J; Cha SI; Kim CH; Kim YT; Jheon S; Son JW; Park JY
    Ann Oncol; 2015 Jun; 26(6):1142-1148. PubMed ID: 25716425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
    Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-binding site SNPs in deregulated genes are associated with clinical outcome of non-small cell lung cancer.
    Xu J; Tian S; Yin Z; Wu S; Liu L; Qian Y; Pei D; Gao W; Xu J; Yin Y; Liu P; Shu Y
    Lung Cancer; 2014 Sep; 85(3):442-8. PubMed ID: 24997136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
    Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
    J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma.
    Campayo M; Navarro A; Viñolas N; Tejero R; Muñoz C; Diaz T; Marrades R; Cabanas ML; Gimferrer JM; Gascon P; Ramirez J; Monzo M
    PLoS One; 2011; 6(7):e22509. PubMed ID: 21799879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants of the Wnt signaling pathway as predictors of recurrence and survival in early-stage non-small cell lung cancer patients.
    Coscio A; Chang DW; Roth JA; Ye Y; Gu J; Yang P; Wu X
    Carcinogenesis; 2014 Jun; 35(6):1284-91. PubMed ID: 24517998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in MicroRNAs are associated with survival in non-small cell lung cancer.
    Zhao Y; Wei Q; Hu L; Chen F; Hu Z; Heist RS; Su L; Amos CI; Shen H; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2503-11. PubMed ID: 25103824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-related single-nucleotide polymorphism of XPO5 is strongly correlated with the prognosis and chemotherapy response in advanced non-small-cell lung cancer patients.
    Geng JQ; Wang XC; Li LF; Zhao J; Wu S; Yu GP; Zhu KJ
    Tumour Biol; 2016 Feb; 37(2):2257-65. PubMed ID: 26358254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer.
    Hong MJ; Lee SY; Choi JE; Jin CC; Kang HJ; Baek SA; Lee SY; Shin KM; Jeong JY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Son JW; Park JY
    Oncotarget; 2016 Mar; 7(13):15948-58. PubMed ID: 26893365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
    Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
    Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients.
    Yang J; Lan H; Huang X; Liu B; Tong Y
    PLoS One; 2012; 7(8):e42978. PubMed ID: 22900072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants of miRNA sequences and non-small cell lung cancer survival.
    Hu Z; Chen J; Tian T; Zhou X; Gu H; Xu L; Zeng Y; Miao R; Jin G; Ma H; Chen Y; Shen H
    J Clin Invest; 2008 Jul; 118(7):2600-8. PubMed ID: 18521189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
    Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
    Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between polymorphisms in microRNA target sites and survival in early-stage non-small cell lung cancer.
    Yoo SS; Hong MJ; Lee JH; Choi JE; Lee SY; Lee J; Cha SI; Kim CH; Seok Y; Lee E; Cho S; Jheon S; Park JY
    Thorac Cancer; 2017 Nov; 8(6):682-686. PubMed ID: 28922562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients.
    Wang S; Wang J; Bai Y; Wang Q; Liu L; Zhang K; Hong X; Deng Q; Zhang X; He M; Wu T; Xu P; Guo H
    Cancer Med; 2016 Sep; 5(9):2332-42. PubMed ID: 27465648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer.
    Glubb DM; Paré-Brunet L; Jantus-Lewintre E; Jiang C; Crona D; Etheridge AS; Mirza O; Zhang W; Seiser EL; Rzyman W; Jassem J; Auman T; Hirsch FR; Owzar K; Camps C; Dziadziuszko R; Innocenti F
    J Thorac Oncol; 2015 Jul; 10(7):1067-75. PubMed ID: 26134224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.
    Chin LJ; Ratner E; Leng S; Zhai R; Nallur S; Babar I; Muller RU; Straka E; Su L; Burki EA; Crowell RE; Patel R; Kulkarni T; Homer R; Zelterman D; Kidd KK; Zhu Y; Christiani DC; Belinsky SA; Slack FJ; Weidhaas JB
    Cancer Res; 2008 Oct; 68(20):8535-40. PubMed ID: 18922928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between microRNA expression, clinicopathological characteristics, and prognosis in patients with Non-small cell Lung Cancer: A retrospective study.
    Wang X; Zhang Y; Zhi X
    Thorac Cancer; 2017 Sep; 8(5):511-516. PubMed ID: 28727276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.
    Wu X; Ye Y; Rosell R; Amos CI; Stewart DJ; Hildebrandt MA; Roth JA; Minna JD; Gu J; Lin J; Buch SC; Nukui T; Ramirez Serrano JL; Taron M; Cassidy A; Lu C; Chang JY; Lippman SM; Hong WK; Spitz MR; Romkes M; Yang P
    J Natl Cancer Inst; 2011 May; 103(10):817-25. PubMed ID: 21483023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.